Benameur Tarek, Porro Chiara, Twfieg Mohammed-Elfatih, Benameur Nassima, Panaro Maria Antonietta, Filannino Francesca Martina, Hasan Abeir
Department of Biomedical Sciences, College of Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.
Brain Sci. 2023 Aug 21;13(8):1226. doi: 10.3390/brainsci13081226.
The human gut microbiota is a complex ecosystem of mutualistic microorganisms that play a critical role in maintaining human health through their individual interactions and with the host. The normal gastrointestinal microbiota plays a specific physiological function in host immunomodulation, nutrient metabolism, vitamin synthesis, xenobiotic and drug metabolism, maintenance of structural and functional integrity of the gut mucosal barrier, and protection against various pathogens. Inflammation is the innate immune response of living tissues to injury and damage caused by infections, physical and chemical trauma, immunological factors, and genetic derangements. Most diseases are associated with an underlying inflammatory process, with inflammation mediated through the contribution of active immune cells. Current strategies to control inflammatory pathways include pharmaceutical drugs, lifestyle, and dietary changes. However, this remains insufficient. Bioactive compounds (BCs) are nutritional constituents found in small quantities in food and plant extracts that provide numerous health benefits beyond their nutritional value. BCs are known for their antioxidant, antimicrobial, anticarcinogenic, anti-metabolic syndrome, and anti-inflammatory properties. Bioactive compounds have been shown to reduce the destructive effect of inflammation on tissues by inhibiting or modulating the effects of inflammatory mediators, offering hope for patients suffering from chronic inflammatory disorders like atherosclerosis, arthritis, inflammatory bowel diseases, and neurodegenerative diseases. The aim of the present review is to summarise the role of natural bioactive compounds in modulating inflammation and protecting human health, for their safety to preserve gut microbiota and improve their physiology and behaviour.
人类肠道微生物群是一个由互利共生微生物组成的复杂生态系统,它们通过个体间的相互作用以及与宿主的相互作用,在维持人类健康方面发挥着关键作用。正常的胃肠道微生物群在宿主免疫调节、营养代谢、维生素合成、外源性物质和药物代谢、维持肠道黏膜屏障的结构和功能完整性以及抵御各种病原体方面发挥着特定的生理功能。炎症是活组织对由感染、物理和化学创伤、免疫因素以及基因紊乱引起的损伤的固有免疫反应。大多数疾病都与潜在的炎症过程相关,炎症是由活跃的免疫细胞介导的。目前控制炎症途径的策略包括药物治疗、生活方式和饮食改变。然而,这仍然不够。生物活性化合物(BCs)是在食物和植物提取物中少量发现的营养成分,它们除了具有营养价值外,还具有许多健康益处。BCs以其抗氧化、抗菌、抗癌、抗代谢综合征和抗炎特性而闻名。生物活性化合物已被证明可以通过抑制或调节炎症介质的作用来减少炎症对组织的破坏作用,这为患有动脉粥样硬化、关节炎、炎症性肠病和神经退行性疾病等慢性炎症性疾病的患者带来了希望。本综述的目的是总结天然生物活性化合物在调节炎症和保护人类健康方面的作用,因为它们对保护肠道微生物群的安全性以及改善其生理和行为有益。
World J Gastroenterol. 2014-12-28
World J Gastroenterol. 2022-8-14
Cell Biochem Biophys. 2015-7
Cancers (Basel). 2022-11-19
AMB Express. 2025-8-8
Probiotics Antimicrob Proteins. 2025-1-14
Endocr Metab Immune Disord Drug Targets. 2025-1-8
Neurotherapeutics. 2024-10
Front Aging Neurosci. 2023-5-30
World J Gastroenterol. 2023-4-14
Comput Struct Biotechnol J. 2023-3-25
Pharmaceuticals (Basel). 2023-2-26
J Clin Med. 2023-2-19